AKTIENANLEIHE - TEVA PHARMACEUTICAL INDUSTRIES Share Price

Certificat

DE000VM17VE8

Market Closed - Deutsche Boerse AG 11:36:23 20/05/2024 pm IST
103.5 EUR +0.12% Intraday chart for AKTIENANLEIHE - TEVA PHARMACEUTICAL INDUSTRIES
Current month+0.95%
1 month+2.00%
Date Price Change
20/24/20 103.5 +0.12%
17/24/17 103.4 -0.05%
16/24/16 103.4 -0.21%
15/24/15 103.7 +0.01%
14/24/14 103.7 +0.04%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 11:36 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Vontobel Vontobel
WKN VM17VE
ISINDE000VM17VE8
Date issued 14/09/2023
Strike 11 $
Maturity 20/09/2024 (123 Days)
Parity 0.01 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 103.7
Lowest since issue 86.11

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
16.29 USD
Average target price
17.34 USD
Spread / Average Target
+6.42%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW